Helen E. Godonis

Weight Loss Induced by Chronic Dapagliflozin Treatment Is Attenuated by Compensatory Hyperphagia in Diet‐Induced Obese (DIO) Rats

James J. Devenny, Helen E. Godonis, Susan J. Harvey et al. · Obesity · 2012 · 216 citations

Life Sciences, Endocrinology, Pharmacology +17

Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated

Jeffrey T. Billheimer, Ira B. Dicker, Richard Wynn et al. · Blood · 2002 · 59 citations · Full text

Medicine, Hematology, Pharmacology +9

Anxiolytic-Like Effects of the Corticotropin-Releasing Factor1 (CRF1) Antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] Administered Acutely or Chronically at Doses Occupying Central CRF1 Receptors in Rats

Snježana Lelas, Harvey Wong, Yu-Wen Li et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 55 citations

Medicine, Pharmacology, Pharmacotherapy +15

Identification of a Nonbasic Melanin Hormone Receptor 1 Antagonist as an Antiobesity Clinical Candidate

William N. Washburn, Mark C. Manfredi, Pratik Devasthale et al. · Journal of Medicinal Chemistry · 2014 · 20 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

Non-basic azolotriazinone MCHR1 antagonists for the treatment of obesity: An empirical brain-exposures-driven candidate selection for in vivo efficacy studies

Pratik Devasthale, Wei Wang, James Mignone et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 15 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13